Carol Webb - 10 Oct 2023 Form 4 Insider Report for Citius Pharmaceuticals, Inc. (CTXR)

Role
Director
Signature
/s/ Alexander M. Donaldson, by power of attorney
Issuer symbol
CTXR
Transactions as of
10 Oct 2023
Net transactions value
$0
Form type
4
Filing time
12 Oct 2023, 16:15:37 UTC
Previous filing
06 Oct 2022
Next filing
30 Aug 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTXR Options to Purchase Common Stock Award $0 +75,000 $0.000000 75,000 10 Oct 2023 Common Stock 75,000 $0.7000 Direct F1
holding CTXR Options to Purchase Common Stock 75,000 10 Oct 2023 Common Stock 75,000 $1.25 Direct F2
holding CTXR Options to Purchase Common Stock 75,000 10 Oct 2023 Common Stock 75,000 $2.04 Direct F3
holding CTXR Options to Purchase Common Stock 15,000 10 Oct 2023 Common Stock 15,000 $2.00 Direct F4
holding CTXR Options to Purchase Common Stock 25,000 10 Oct 2023 Common Stock 25,000 $1.69 Direct F5
holding CTXR Options to Purchase Common Stock 35,000 10 Oct 2023 Common Stock 35,000 $1.01 Direct F6
holding CTXR Options to Purchase Common Stock 25,000 10 Oct 2023 Common Stock 25,000 $1.39 Direct F7
holding CTXR Options to Purchase Common Stock 25,000 10 Oct 2023 Common Stock 25,000 $0.6700 Direct F8
holding CTXR Options to Purchase Common Stock 15,000 10 Oct 2023 Common Stock 15,000 $1.62 Direct F9
holding CTXR Options to Purchase Common Stock 10,000 10 Oct 2023 Common Stock 10,000 $3.45 Direct F10
holding CTXR Options to Purchase Common Stock 12,071 10 Oct 2023 Common Stock 12,071 $0.0150 Direct F11
holding CTXR Options to Purchase Common Stock 13,334 10 Oct 2023 Common Stock 13,334 $12.00 Direct F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on October 10, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.
F2 The options vested in full on October 4, 2023.
F3 The options vested in full on October 11, 2022.
F4 The options vested in full on July 22, 2022.
F5 The options vested in full on February 16, 2022.
F6 The options vested in full on October 6, 2021.
F7 The options vested in full on July 7, 2021.
F8 The options vested in full on October 8, 2020.
F9 The options vested in full on September 4, 2019.
F10 The options vested in full on September 13, 2018.
F11 The options vested in full on March 17, 2017.
F12 The options vested in full on June 23, 2017.